StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3024% above fair value
$1409.38−1.61 (-0.11%)

Close on Nov 3, 2026Market cap $1.33TP/E 45.7Yield 0.44%

Eli Lilly Intangible asset amortization expense by Year

Intangible asset amortization expense ($M) ($M)

Eli Lilly Intangible asset amortization expense: $488M in FY2025, down 11.8% from a year earlier.

Latest, FY2025
488
Period ended Dec 31, 2025
Change on a year earlier
-11.8%
553 in FY2024
History
10 years
Since FY2016
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-12) ↗

Reported in Form 10-K Goodwill & Intangibles Note.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIntangible asset amortization expense ($M) ($M)Year on yearSource
FY2025Dec 31, 2025488-11.8%Form 10-K (filed 2026-02-12) ↗
FY2024Dec 31, 2024553+9.3%Form 10-K (filed 2026-02-12) ↗
FY2023Dec 31, 2023506-12.7%Form 10-K (filed 2026-02-12) ↗
FY2022Dec 31, 2022580-7.8%Form 10-K (filed 2025-02-19) ↗
FY2021Dec 31, 2021629+46.8%Form 10-K (filed 2024-02-21) ↗
FY2020Dec 31, 2020428+89.6%Form 10-K (filed 2023-02-22) ↗
FY2019Dec 31, 2019226-37.5%Form 10-K (filed 2022-02-23) ↗
FY2018Dec 31, 2018361-21.8%Form 10-K (filed 2021-02-17) ↗
FY2017Dec 31, 2017462-32.8%Form 10-K (filed 2020-02-19) ↗
FY2016Dec 31, 2016688–Form 10-K (filed 2019-02-19) ↗

Cite this data

StockData. (2026). Eli Lilly Intangible asset amortization expense ($M), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/intang-amort-expense

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.

See a number that looks wrong?